DILIsym Services Overview

  • Founded
  • 2011
  • Status
  • Acquired/​Merged
  • Employees
  • 11
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

DILIsym Services General Information


Developer of drug-induced liver injury simulation software designed to help ensure the safety of drug therapies. The company's DILIsym software is designed to be used during drug development to provide an enhanced understanding of the DILI hazard posed by individual molecules and to provide deeper insight into the mechanisms responsible for observed DILI responses at various stages of the development process.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Decision/Risk Analysis
Parent Company
Primary Office
  • P.O. Box 12317
  • NC 27709
  • United States
+1 (919) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DILIsym Services Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DILIsym Services‘s full profile, request access.

Request a free trial

DILIsym Services Executive Team (2)

Name Title Board Seat Contact Info
Brett Howell Ph.D Chief Executive Officer & Board of Director
Scott Siler Ph.D President & Director
To view DILIsym Services’s complete executive team members history, request access »

DILIsym Services Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial